Unraveling the pathogenesis of Parkinson's disease--the contribution of monogenic forms

Cellular and Molecular Life Sciences : CMLS
Vincenzo BonifatiP Heutink

Abstract

The field of Parkinson's disease pathogenesis is rapidly evolving from the one of a monolithic and obscure entity into the one of a complex scenario with several known molecular players. The ongoing systematic exploration of the genome holds great promise for the identification of the genetic factors conferring susceptibility to the common non-Mendelian forms of this disease. However, most of the progress of the last 5 years has come from the successful mapping and cloning of genes responsible for rare Mendelian variants of Parkinson's disease. These discoveries are providing tremendous help in understanding the molecular mechanisms of this devastating disease. Here we review the genetics of the monogenic forms of Parkinson's disease. Moreover, we focus on the mechanisms of disease caused by alpha-synuclein and parkin mutations, and the implications of this growing body of knowledge for understanding the pathogenesis of the common forms of the disease.

Citations

Jul 7, 2006·Cellular and Molecular Neurobiology·Toshi Nagatsu, Makoto Sawada
Nov 3, 2005·Current Neurology and Neuroscience Reports·Vincenzo Bonifati
Dec 8, 2005·European Journal of Human Genetics : EJHG·Alessio Di FonzoUNKNOWN Italian Parkinson's Genetics Network
Apr 30, 2013·Journal of Neuroinflammation·Thi A NguyenMalú G Tansey
Feb 1, 2007·Neuropsychiatric Disease and Treatment·Clelia PellicanoFrancesco E Pontieri
Dec 11, 2013·Molecular Neurobiology·Ramavati PalSimon Geir Møller
Jul 15, 2009·Neurobiology of Disease·Robert E DroletJ Timothy Greenamyre
Nov 1, 2008·Movement Disorders : Official Journal of the Movement Disorder Society·Maria G MacedoPeter Heutink
Feb 1, 2005·Lancet·Alessio Di FonzoUNKNOWN Italian Parkinson Genetics Network
Jul 13, 2005·Mutation Research·Luba M Pardo, Cornelia M van Duijn
May 18, 2010·Biochimica Et Biophysica Acta·Yannic WaerzeggersAndreas H Jacobs
Dec 20, 2005·Lancet Neurology·Eduardo TolosaWerner Poewe
Nov 1, 2005·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·P SerdarogluM Emre
Jun 15, 2007·Expert Review of Neurotherapeutics·Ennio EspositoGiuseppe Di Giovanni
Sep 2, 2008·Expert Review of Neurotherapeutics·Pasquale Montagna
Oct 3, 2006·Expert Review of Neurotherapeutics·Elly M HolWiep Scheper
Nov 1, 2007·Proteomics. Clinical Applications·Mauro FasanoLeonardo Lopiano
Jul 13, 2006·European Journal of Human Genetics : EJHG·Vincenzo Bonifati
Nov 15, 2005·Journal of Neural Transmission·N Vanacore
Feb 8, 2006·Journal of Neuropathology and Experimental Neurology·Estifanos GhebremedhinHeiko Braak
May 10, 2008·Expert Review of Proteomics·Mauro Fasano, Leonardo Lopiano
Jan 6, 2011·Journal of Neural Transmission·Daniela Berg
Apr 8, 2011·Acta Neurologica Scandinavica·H DengJ Jankovic
Feb 8, 2006·Journal of Neuropathology and Experimental Neurology·Barbara SerafiniFrancesca Aloisi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alpha-Synuclein Aggregation (MDS)

Alpha-synucleins are small proteins that are believed to restrict the mobility of synpatic vesicles and inhibit neurotransmitter release. Aggregation of these proteins have been linked to several types of neurodegenerative diseases including dementia with Lewy bodies and Parkinson's disease. Here is the latest research on α-synuclein aggregation.

© 2022 Meta ULC. All rights reserved